What is he best known for?
The fields of study he is best known for:
- Immune system
- Cytokine
- Antibody
Willi K. Born spends much of his time researching Immunology, T cell, Antigen, T-cell receptor and Immune system.
The Immunology study combines topics in areas such as Cytotoxic T cell and Lung.
The various areas that Willi K. Born examines in his T cell study include Receptor and Molecular biology.
Willi K. Born studies Antigen, namely Epitope.
The concepts of his T-cell receptor study are interwoven with issues in Innate immune system, T lymphocyte, Interleukin 17 and Major histocompatibility complex.
His research integrates issues of Alpha, Pathology and Cell biology in his study of Immune system.
His most cited work include:
- γδ T cell effector functions: a blend of innate programming and acquired plasticity (642 citations)
- Stimulation of a major subset of lymphocytes expressing T cell receptor γδ by an antigen derived from mycobacterium tuberculosis (405 citations)
- IL-17A Produced by γδ T Cells Plays a Critical Role in Innate Immunity against Listeria monocytogenes Infection in the Liver (306 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, T cell, T-cell receptor, Antigen and Immune system.
His study ties his expertise on Cytotoxic T cell together with the subject of Immunology.
His T cell research is multidisciplinary, relying on both CD8, Cytokine and Function, Cell biology.
His T-cell receptor research incorporates elements of Molecular biology, T lymphocyte, Receptor and Gene.
His Antigen study combines topics in areas such as Heat shock protein, Spleen and Biochemistry, Peptide.
His study in Immune system is interdisciplinary in nature, drawing from both Allergy, Immunoglobulin E, In vivo and Bacteria.
He most often published in these fields:
- Immunology (71.70%)
- T cell (54.72%)
- T-cell receptor (50.31%)
What were the highlights of his more recent work (between 2012-2020)?
- Immunology (71.70%)
- T cell (54.72%)
- T-cell receptor (50.31%)
In recent papers he was focusing on the following fields of study:
Willi K. Born mainly focuses on Immunology, T cell, T-cell receptor, Immune system and Antigen.
His studies in T cell integrate themes in fields like Cytotoxic T cell, Receptor and Interleukin 17.
His Receptor research incorporates themes from Extracellular and Adenosine.
His T-cell receptor research is multidisciplinary, incorporating perspectives in Molecular biology, Gene and Cytokine.
His Immune system study which covers Uveitis that intersects with Pathogenesis, Cell and Regulatory T cell.
His Antigen research is multidisciplinary, incorporating elements of Cancer, Cancer immunology and Immunotherapy.
Between 2012 and 2020, his most popular works were:
- Diversity of γδ T-cell antigens (76 citations)
- Dermal γδ T cells – What have we learned? (41 citations)
- IL-23 Receptor Expression on γδ T Cells Correlates with Their Enhancing or Suppressive Effects on Autoreactive T Cells in Experimental Autoimmune Uveitis (34 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Cytokine
- Antibody
Willi K. Born focuses on Immunology, T cell, Interleukin 17, Cytotoxic T cell and Antigen-presenting cell.
His is doing research in T-cell receptor, Immune system, IL-2 receptor, Interleukin 21 and Autoimmunity, both of which are found in Immunology.
He has researched T-cell receptor in several fields, including Receptor, Dermis, Freund's adjuvant and Interferon gamma.
He studied Interleukin 21 and Natural killer T cell that intersect with Interleukin 3.
As part of one scientific family, Willi K. Born deals mainly with the area of Autoimmunity, narrowing it down to issues related to the Immunoglobulin E, and often B cell and Adoptive cell transfer.
His studies deal with areas such as Major histocompatibility complex and Antigen as well as Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
